Aligos Therapeutics, Inc. (ALGS)
Nasdaq: ALGS · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 5, 2026 | Mar 10, 2025 | Mar 12, 2024 | Mar 9, 2023 | Mar 10, 2022 | Mar 23, 2021 | · |
| Revenue | 2,186 | 3,611 | 6,191 | 0 | 0 | 0 | · |
| For lenders | |||||||
| Net interest income | 2,200 | 1,700 | 4,300 | 1,500 | · | · | · |
| Research and development | 69,453 | 70,269 | 73,040 | 85,077 | 104,153 | 79,890 | 44,038 |
| General and administrative | 20,718 | 22,830 | 30,616 | 26,410 | 28,527 | 17,944 | 10,005 |
| Total operating expenses | 90,171 | 93,099 | 103,656 | 111,487 | 132,680 | 97,834 | 54,043 |
| Operating income | -87,985 | -89,154 | -88,127 | -97,580 | -128,321 | -97,834 | -54,043 |
| Income before income taxes | -23,879 | -130,880 | -86,884 | -95,940 | -128,189 | -108,382 | -52,179 |
| Income tax expense | 314 | 331 | 795 | 106 | 143 | 161 | 85 |
| Net income | -24,193 | -131,211 | -87,679 | -96,046 | -128,332 | -108,543 | -52,264 |
| Earnings per share, basic | -2.45 | -20.94 | -34.20r | -56.25b | · | · | · |
| Earnings per share, diluted | -2.45 | -20.94 | -34.20r | -56.25b | · | · | · |
| Earnings per share, basic and diluted | · | · | · | -56.25b | -80.50b | -271.75b | -651.00b |
| Weighted average shares, basic | 9,884,955 | 6,264,612 | 2,563,470r | 1,707,809b | · | · | · |
| Weighted average shares, diluted | 9,884,955 | 6,264,612 | 2,563,470r | 1,707,809b | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | 1,707,809b | 1,594,216b | 399,528b | 80,287b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split of Aug 2024.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted